BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33472173)

  • 1. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
    Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T; Bai X; Liu K; Hu W; Xue D; Jiang X
    J Tongji Med Univ; 1998; 18(3):161-3. PubMed ID: 10806816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
    Ashton C; Rhie SK; Carmichael JD; Zada G
    J Neurosurg; 2020 Feb; 134(3):787-793. PubMed ID: 32109873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
    Shao S; Li X
    J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
    Mo C; Chen H; Xu J; Guo Y; Wang Y; Li Z; Tong T; Gui S; Zhong L
    Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Biology of Pituitary Adenomas.
    Faltermeier CM; Magill ST; Blevins LS; Aghi MK
    Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homeoproteins and pituitary adenoma].
    Barlier A; Pellegrini-Bouiller I; Gunz G; Jaquet P; Enjalbert A
    Ann Endocrinol (Paris); 1997; 58(1):3-10. PubMed ID: 9207961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
    Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
    Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
    [No Abstract]   [Full Text] [Related]  

  • 13. Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas.
    Uccella S; Tibiletti MG; Bernasconi B; Finzi G; Oldrini R; Capella C
    Anal Quant Cytol Histol; 2005 Oct; 27(5):241-52. PubMed ID: 16447816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.
    Chauvet N; Romanò N; Meunier AC; Galibert E; Fontanaud P; Mathieu MN; Osterstock G; Osterstock P; Baccino E; Rigau V; Loiseau H; Bouillot-Eimer S; Barlier A; Mollard P; Coutry N
    J Neuroendocrinol; 2016 Feb; 28(2):12352. PubMed ID: 26686489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction.
    Evans CO; Young AN; Brown MR; Brat DJ; Parks JS; Neish AS; Oyesiku NM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3097-107. PubMed ID: 11443173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
    Lania AG; Ferrero S; Pivonello R; Mantovani G; Peverelli E; Di Sarno A; Beck-Peccoz P; Spada A; Colao A
    J Clin Endocrinol Metab; 2010 Jan; 95(1):13-7. PubMed ID: 19890024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
    Pivonello C; Patalano R; Negri M; Pirchio R; Colao A; Pivonello R; Auriemma RS
    Front Endocrinol (Lausanne); 2021; 12():791633. PubMed ID: 35095761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of survivin splice variants in pituitary tumors.
    Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Kubiczak M; Jankowska A; Liebert W; Czarnywojtek A; Waśko R; Blanco-Gangoo AR; Ruchała M
    Pituitary; 2015 Jun; 18(3):410-6. PubMed ID: 25107550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of 15-hydroxyprostaglandin dehydrogenase indicates a tumor suppressor role in pituitary adenomas.
    Bai JW; Wang Z; Gui SB; Zhang YZ
    Oncol Rep; 2012 Aug; 28(2):714-20. PubMed ID: 22580984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.